1,2-cyclohexanediamine has been researched along with Stroke in 1 studies
1,2-cyclohexanediamine: RN given refers to cpd without isomeric designation
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haas, S | 1 |
| Camm, JA | 1 |
| Harald, D | 1 |
| Steffel, J | 1 |
| Virdone, S | 1 |
| Pieper, K | 1 |
| Brodmann, M | 1 |
| Schellong, S | 1 |
| Misselwitz, F | 1 |
| Kayani, G | 1 |
| Kakkar, AK | 1 |
1 other study available for 1,2-cyclohexanediamine and Stroke
| Article | Year |
|---|---|
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Austria; Humans; Registries; Risk Factors | 2023 |